Skip to main content
. 2020 Jul 7;12:5515–5525. doi: 10.2147/CMAR.S242800

Table 1.

Distribution of Patient Characteristics in the Tracheal Intubation and Tracheotomy Groups, Before and After Propensity Score Matching

Characteristics Before Matching P value After Matching P value
Tracheal Intubation Group Tracheotomy Group Tracheal Intubation Group Tracheotomy Group
Total 515 326 298 298
Age 60.17±8.9 60.93±9.4 0.248 60.38±9.5 60.79±8.8 0.623
Age < 60 (yr) 252 (49) 151 (46) 0.479 137 (46) 138 (46) 1.000
Male 500 (97) 316 (97) 0.897 288 (96) 289 (97) 0.816
BMI (kg/m2) 21.8 ± 3.1 22.0 ± 3.2 0.255 21.5 ± 3.1 21.9 ± 3.1 0.752
Smoking index 531 604 0.058 591 552 0.896
Alcohol intake 135 (26) 92 (28) 0.523 77 (25) 84 (28) 0.518
Hypertension 88 (17) 48 (14) 0.364 50 (16) 44 (15) 0.500
Diabetes 29 (6) 16 (5) 0.650 14 (5) 15 (5) 0.849
Cardiac disease 16 (3) 10 (3) 0.974 13 (4) 10 (3) 0.523
ASA
 2 237 (46) 137 (42) 0.178 132 (44) 123 (41) 0.524
 3 257 (50) 181 (56) 156 (52) 168 (56)
 4 21 (4) 8 (2) 10 (4) 7 (3)
Cancer history 24 (5) 8 (3) 0.103 14 (5) 6 (2) 0.069
Opioids (morphine, mg) 62.3 ± 1.1 74.1 ± 1.6 0.007* 70.4 ± 1.5 70.9 ± 1.6 0.436
Type of surgery
 Partial laryngectomy 247 (48) 89 (27) <0.001* 99 (33) 88 (30) 0.332
 Total laryngectomy 268 (52) 237 (73) 199 (67) 210 (70)
Neck dissection 271 (53) 190 (58) 0.108 184 (62) 170 (57) 0.243
Anesthesia time (h) 2.8 ± 1.3 3.4 ± 1.4 0.030* 3.2 ± 1.3 3.2 ± 1.3 0.914
Blood transfusion 1 (0.2) 0 0.426 1 (0.3) 0 0.317
Primary cite of cancer
 Supraglottic 104 (20) 78 (24) 0.438 59 (20) 70 (24) 0.505
 Glottic 400 (78) 241 (74) 230 (77) 221 (74)
 Subglottic 11 (2) 7 (2) 9 (3) 7 (2)
Tumor Differentiation
 Poorly differentiated 80 (16) 46 (14) 0.755 47 (16) 39 (13) 0.626
 Moderately differentiated 289 (56) 181 (56) 162 (54) 170 (57)
 Highly differentiated 146 (28) 99 (30) 89 (30) 89 (30)
T classification
 1 75 (15) 19 (6) <0.001* 21 (7) 19 (6) 0.967
 2 159 (30) 79 (24) 74 (25) 78 (26)
 3 180 (35) 130 (40) 113 (38) 114 (38)
 4 101 (20) 98 (30) 90 (30) 87 (30)
N classification
 0 394 (77) 244 (75) 0.208 220 (74) 228 (77) 0.213
 1 51 (9) 44 (14) 30 (10) 36 (12)
 2 67 (13) 38 (12) 46 (15) 34 (11)
 3 3 (1) 0 2 (1) 0
Clinical stage
 I/II 204 (40) 85 (26) <0.001* 85 (28) 84 (28) 0.920
 III/IV 311 (60) 241 (74) 213 (72) 214 (72)
Postoperative complications 23 (4) 22 (7) 0.152 18 (6) 21 (7) 0.619
Preoperative radiotherapy 18 (4) 22 (7) 0.031* 13 (4) 16 (5) 0.568
Preoperative chemotherapy 15 (3) 10 (3) 0.897 10 (3) 8 (3) 0.632
Postoperative radiotherapy 88 (17) 52 (16) 0.666 62 (21) 45 (15) 0.070
Postoperative chemotherapy 19 (4) 27 (8) 0.004* 15 (5) 15 (5) 1.000

Notes: Data are the median, or number and percentage (%), analyzed with a Fisher’s exact test, χ2-test or two-sample t test. *P<0.05 is statistically significant.

Abbreviations: BMI, body mass index; ASA, American society of Anesthesiology; T classification, tumor classification of tumor, node and metastasis classification of cancer; N classification, node classification of tumor, node and metastasis classification of cancer.